Menopausal hormone use and endometrial cancer, by tumor grade and invasion

Epidemiology

Volumn 9, Issue 1, 1998, Pages 99-101

  Shapiro, Jean A ^a,b   Weiss, Noel S ^a   Beresford, Shirley A A ^a   Voigt, Lynda F ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Case control studies; Endometrial neoplasms; Estrogen replacement therapy; Progestational hormones

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENDOMETRIUM CANCER; ESTROGEN THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 0031963909     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-199801000-00020     Document Type: Article

References (9)

1. Herrinton LJ, Weiss NS. Postmenopausal unopposed estrogens: characteristics of use in relation to risk of endometrial carcinoma. Ann Epidemiol 1993;3:308-318.
2. Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995;85:304-313.
3. Voigt LF, Weiss NS, Chu J, Daling JR, McKnight B, Van Belle G. Progestogen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet 1991;338:274-277.
4. Chu J, Schweid AL, Weiss NS. Survival among women with endometrial cancer: a comparison of estrogen users and nonusers. Am J Obstet Gynecol 1982;143:569-573.
5. DiSaia PJ, Creasman WT, Boronow RC, Blessing JA. Risk factors and recurrent patterns in Stage I endometrial cancer. Am J Obstet Gynecol 1985;151:1009-1015.
6. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, Graham JE. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991;40:55-65.
7. Waksberg J. Sampling methods for random digit dialing. J Am Stat Assoc 1978;73:40-46.
8. Beresford SAA, Weiss NS, Voigt L, McKnight B. Endometrial cancer risk in relation to use of estrogen combined with cyclic progestin therapy in postmenopausal women. Lancet 1997;349:458-461.
9. Brinton LA, Hoover RN, and the Endometrial Cancer Collaborative Group. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. Obstet Gynecol 1993;81:265-271.